The FDA’s new drug center director, George Tidmarsh, was recently appointed by HHS Secretary Robert F. Kennedy Jr. Tidmarsh, a longtime biotech executive, will now be leading the agency’s efforts in regulating drugs.
This move comes as part of Kennedy’s push to sever ties between the FDA and drugmakers, aiming to ensure a more transparent and independent regulatory process. Tidmarsh’s background in the biotech industry brings a wealth of experience to the role, and he is expected to bring a fresh perspective to the agency.
In other news, D.C. Diagnosis is calling for readers to share their favorite artificial-dye-free ice cream flavors. Whether it’s cardamom or another unique flavor, they want to hear from you. Readers can also send in news tips to the email address provided or contact John_Wilkerson.07 on Signal.
For more exclusive content and in-depth analysis, readers can subscribe to STAT+. This subscription service offers access to premium events, newsletters, and news alerts, providing a comprehensive source of information on the politics and policy of health and medicine.
Stay tuned for more updates on the latest developments in the world of health and medicine with D.C. Diagnosis.
